Studies [10, 40] have shown that PI3K-Akt plays a key link in multidrug resistance, but in some cases activation of PI3K-Akt pathway alone is not sufficient to lead to the development of tumor chemoresistance. The gene discussed is AKT1; the disease is neoplasm.